Telegraph.co.uk MedImmune parent, Amgen launch partnership Gazette.Net: Maryland Community News Online by Gazette Staff Amgen and AstraZeneca, through its global biologics division, MedImmune of Gaithersburg, are partnering to develop and tap five monoclonal antibodies to treat a wide reach of conditions, from disease of the skin to Crohn's disease and ... UPDATED: AstraZeneca pays $50M to partner ahead on Amgen antibodies FierceBiotech Big Pharma Buys accession to This Promising Biotech Pipeline Motley Fool AstraZeneca and Amgen forge antibody alliance PMLiVE PR Newswire (press release) - Reuters UK - Bizjournals.com (blog) all 12 news articles » Link To Article
No comments:
Post a Comment